KANGJI MED.HLDS DL-00001
Kangji Medical Holdings Limited, an investment holding company, designs, develops, manufactures, and sells minimally invasive surgical instruments and accessories in Mainland China and internationally. The company offers disposable consumables, disposable trocars, disposable electrocoagulation forceps, ultrasonic scalpels, staplers and other disposable products. It provides reusable ultrasonic sc… Read more
KANGJI MED.HLDS DL-00001 (50J) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, KANGJI MED.HLDS DL-00001 (50J) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
KANGJI MED.HLDS DL-00001 - Net Assets Trend (None–None)
This chart illustrates how KANGJI MED.HLDS DL-00001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for KANGJI MED.HLDS DL-00001 (None–None)
The table below shows the annual net assets of KANGJI MED.HLDS DL-00001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to KANGJI MED.HLDS DL-00001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
KANGJI MED.HLDS DL-00001 Competitors by Market Cap
The table below lists competitors of KANGJI MED.HLDS DL-00001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BUMI RESOURC.MINER.RP 625
F:BUR
|
$780.79 Million |
|
Shanghai Environment Group Co Ltd
SHG:601200
|
$780.80 Million |
|
ITH0
F:ITH0
|
$780.92 Million |
|
Shandong Bohui Paper Industry Co Ltd
SHG:600966
|
$781.21 Million |
|
Suzhou Jinfu New Material Co
SHE:300128
|
$780.39 Million |
|
ACEA S.p.A
OTCGREY:ACEJF
|
$780.10 Million |
|
ATOSS Software SE
F:AOF
|
$780.09 Million |
|
Tokai Carbon Korea Co. Ltd
KQ:064760
|
$779.88 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in KANGJI MED.HLDS DL-00001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares KANGJI MED.HLDS DL-00001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently KANGJI MED.HLDS DL-00001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares KANGJI MED.HLDS DL-00001's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| KANGJI MED.HLDS DL-00001 (50J) | €- | N/A | N/A | $780.43 Million |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $213.74 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $475.06 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $32.92 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $217.64 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $658.78 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $783.58 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.63 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.27 Billion |